No7 Future Renew Damage Reversal Serum – Anti-Aging Face for Glowing Skin Hyaluronic Acid + Niacinamide Dermatologist-Approved, Suitable Sensitive (25ml)
Original price was: $26.50.$25.98Current price is: $25.98.
Price: $26.50 - $25.98
(as of Jun 25, 2024 15:54:34 UTC – Details)
From the brand
Future Renew Collection
Skincare Bestsellers
Makeup Bestsellers
Is Discontinued By Manufacturer : No
Product Dimensions : 1.4 x 1.8 x 5.2 inches; 0.88 ounces
Manufacturer : The Boots Company PLC
ASIN : B0C2J7Z91J
Country of Origin : United Kingdom
In a consumer study, 92% of women said their skin looked less damaged after using the No7 Future Renew face serum for women.** **Consumer study over 8 weeks.
In a consumer study, from the first use of this hydrating serum, women said their skin looked brighter and felt less dry, renewed and firmer.* *Consumer study.
After 1 week of using this hyaluronic acid serum for face, skin tone and texture look more even, the appearance of dryness is improved, and fine lines appear reduced.* *Consumer study.
Fast-absorbing and non-greasy, this anti-aging serum has a lightweight texture and works well under makeup. This facial serum is the perfect addition to your skincare and makeup routine.
Like many No7 facial skin care products, Future Renew hyaluronic acid serum is dermatologist-approved and suitable for sensitive skin. Discover more facial serums for sensitive skin at the No7 Amazon store.
Customers say
Customers like the ease of use, lines, and weight of the skin serum. They mention that it goes on smoothly, it’s light, and that it makes their skin look and feel younger. They are also happy with appearance, greasiness, and quality. That said, some disagree on value and size.
AI-generated from the text of customer reviews
User Reviews
Be the first to review “No7 Future Renew Damage Reversal Serum – Anti-Aging Face for Glowing Skin Hyaluronic Acid + Niacinamide Dermatologist-Approved, Suitable Sensitive (25ml)”
Original price was: $26.50.$25.98Current price is: $25.98.
There are no reviews yet.